Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs SYNCOM HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA SYNCOM HEALTHCARE BLISS GVS PHARMA/
SYNCOM HEALTHCARE
 
P/E (TTM) x 13.2 -3.6 - View Chart
P/BV x 1.4 - - View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   SYNCOM HEALTHCARE
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
SYNCOM HEALTHCARE
Mar-20
BLISS GVS PHARMA/
SYNCOM HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs912 3,887.2%   
Low Rs671 9,614.3%   
Sales per share (Unadj.) Rs72.25.0 1,445.7%  
Earnings per share (Unadj.) Rs7.4-2.9 -251.5%  
Cash flow per share (Unadj.) Rs9.2-2.4 -388.7%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.0-3.1 -2,706.8%  
Shares outstanding (eoy) m104.1540.00 260.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.10.3 359.8%   
Avg P/E ratio x10.8-0.5 -2,068.5%  
P/CF ratio (eoy) x8.7-0.6 -1,338.4%  
Price / Book Value ratio x0.9-0.5 -192.2%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,26261 13,544.1%   
No. of employees `000NANA-   
Total wages/salary Rs m86250 1,722.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,516200 3,764.2%  
Other income Rs m1783 6,840.8%   
Total revenues Rs m7,694202 3,803.7%   
Gross profit Rs m1,173-94 -1,248.4%  
Depreciation Rs m18723 815.1%   
Interest Rs m1043 3,586.2%   
Profit before tax Rs m1,061-117 -905.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2930-   
Profit after tax Rs m767-117 -654.8%  
Gross profit margin %15.6-47.1 -33.2%  
Effective tax rate %27.70-   
Net profit margin %10.2-58.7 -17.4%  
BALANCE SHEET DATA
Current assets Rs m6,97447 14,853.4%   
Current liabilities Rs m1,933182 1,061.0%   
Net working cap to sales %67.1-67.7 -99.1%  
Current ratio x3.60.3 1,400.0%  
Inventory Days Days3932 120.3%  
Debtors Days Days1,87146 4,099.6%  
Net fixed assets Rs m4,562131 3,474.1%   
Share capital Rs m104400 26.0%   
"Free" reserves Rs m8,646-524 -1,649.5%   
Net worth Rs m8,750-124 -7,047.9%   
Long term debt Rs m407117 347.9%   
Total assets Rs m11,535178 6,471.4%  
Interest coverage x11.2-39.6 -28.4%   
Debt to equity ratio x0-0.9 -4.9%  
Sales to assets ratio x0.71.1 58.2%   
Return on assets %7.6-64.1 -11.8%  
Return on equity %8.894.4 9.3%  
Return on capital %12.71,591.9 0.8%  
Exports to sales %00.5 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6181 540,226.9%   
Fx outflow Rs m1,2250-   
Net fx Rs m4,3941 422,481.7%   
CASH FLOW
From Operations Rs m343-1 -39,441.4%  
From Investments Rs m-786 -1,384.1%  
From Financial Activity Rs m-249-3 8,629.4%  
Net Cashflow Rs m302 1,641.3%  

Share Holding

Indian Promoters % 35.0 0.1 26,900.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 0.0 -  
FIIs % 15.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 99.9 65.1%  
Shareholders   40,758 29,298 139.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs SYNCOM HEALTHCARE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs SYNCOM HEALTHCARE Share Price Performance

Period BLISS GVS PHARMA SYNCOM HEALTHCARE S&P BSE HEALTHCARE
1-Day -0.57% -0.72% 1.17%
1-Month -8.43% 17.71% -0.76%
1-Year 59.45% 36.88% 61.80%
3-Year CAGR 4.16% 0.00% 18.16%
5-Year CAGR -8.61% -11.36% 19.78%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the SYNCOM HEALTHCARE share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of SYNCOM HEALTHCARE the stake stands at 0.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of SYNCOM HEALTHCARE.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

SYNCOM HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of SYNCOM HEALTHCARE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.